PUMA BIOTECHNOLOGY, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Puma Biotechnology, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Puma Biotechnology, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $369M, a 1.66% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $369M -$6.21M -1.66% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $375M -$5.14M -1.35% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $380M -$12.5M -3.18% Dec 31, 2021 10-K 2024-02-29
Q4 2020 $393M +$8.66M +2.25% Dec 31, 2020 10-K 2023-03-02
Q4 2019 $384M +$14.2M +3.85% Dec 31, 2019 10-K 2022-03-03
Q4 2018 $370M +$5.53M +1.52% Dec 31, 2018 10-K 2020-02-28
Q4 2017 $364M +$48.1M +15.2% Dec 31, 2017 10-K 2019-03-01
Q4 2016 $316M +$106M +50.6% Dec 31, 2016 10-K 2018-03-09
Q4 2015 $210M +$101M +93.5% Dec 31, 2015 10-K 2017-03-01
Q4 2014 $108M +$49.8M +84.9% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $58.6M +$25.4M +76.3% Dec 31, 2013 10-K 2015-03-02
Q4 2012 $33.3M +$29.2M +721% Dec 31, 2012 10-K 2014-03-03
Q4 2011 $4.05M Dec 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.